CHD7 and CHARGE syndrome: A CHARGE syndrome-associated mutation in the first chromodomain (S834F) completely abolished CHD7 activity and mutations in the second chromodomain (K907T and T917M) significantly affected remodelling activity, with K907T being the most severe.